nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Acknowledgement to Referees
|
|
|
|
42 |
12 |
p. 1021-1024 |
artikel |
2 |
Budget Impact Analysis of Idecabtagene Vicleucel for the Treatment of Adult Patients with Relapsed or Refractory Multiple Myeloma in the US
|
Ghanem, Buthainah |
|
|
42 |
12 |
p. 1085-1092 |
artikel |
3 |
Cost-Utility Analysis Comparing Direct Oral Anticoagulant and Low Molecular Weight Heparin Therapies for Secondary Prevention of Cancer-Associated Thrombosis
|
Shin, Young Eun |
|
|
42 |
12 |
p. 1075-1083 |
artikel |
4 |
COVID-19 mRNA Vaccines: A Retrospective Observational Pharmacovigilance Study
|
Ferrara, Francesco |
|
|
42 |
12 |
p. 1065-1074 |
artikel |
5 |
Depicting Risperidone Safety Profiles in Clinical Trials Across Different Diagnoses Using a Dopamine D2-Based Pharmacological Class Effect Query Defined by FAERS
|
Hopkins, Seth C. |
|
|
42 |
12 |
p. 1113-1121 |
artikel |
6 |
Efficacy and Safety of Saroglitazar in Patients with Cardiometabolic Diseases: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
|
Durga, Devarapalli Ranjani |
|
|
42 |
12 |
p. 1049-1064 |
artikel |
7 |
Pharmacokinetics of Glepaglutide, A Long-Acting Glucagon-Like Peptide-2 Analogue: A Study in Healthy Subjects
|
Agersnap, Mikkel Askjær |
|
|
42 |
12 |
p. 1093-1100 |
artikel |
8 |
Pharmacokinetics of Morphine Sulfate Orodispersible Tablets and Bioequivalence with Immediate-Release Oral Morphine Sulfate Formulations in Healthy Adult Subjects Under Fasting Conditions: Single-Dose Comparative Bioavailability Studies
|
Atrux-Tallau, Nicolas |
|
|
42 |
12 |
p. 1101-1112 |
artikel |
9 |
SGLT2 Inhibitors Improve Cardiac Failure by Reducing Whole-Body Oxygen Demand: A Hypothesis
|
Onoue, Takeshi |
|
|
42 |
12 |
p. 1025-1030 |
artikel |
10 |
The Effect of Nitazoxanide on the Clinical Outcomes in Patients with COVID-19: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
|
Abuelazm, Mohamed |
|
|
42 |
12 |
p. 1031-1047 |
artikel |